Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Murine norovirus (MNV) replication machinery is a multi-protein complex essential for the life cycle of MNV, a member of the Caliciviridae family (Thorne and Goodfellow, 2014). This machinery is primarily composed of seven non-structural proteins (NS1-NS7) encoded by the viral Open Reading Frame 1 (ORF1). Key enzymatic activities within this complex include the NS6 protease, which is responsible for the proteolytic processing of the viral polyprotein, and the NS7 RNA-dependent RNA polymerase (RdRp), which facilitates the replication of the positive-sense RNA genome (Arias et al., 2012). Because MNV can be efficiently grown in cell culture and shares significant structural and functional homology with human noroviruses, it serves as the gold-standard surrogate model for studying norovirus replication and testing potential therapeutics (Wobus et al., 2006). Antiviral strategies targeting this machinery often focus on nucleoside analogs that cause chain termination or lethal mutagenesis during RNA synthesis, as well as small-molecule inhibitors that block protease activity (Rocha-Pereira et al., 2014). Inhibiting these components effectively prevents the production of new viral progeny, making the replication machinery a high-priority target for treating norovirus-induced gastroenteritis.
Inhibition of viral RNA-dependent RNA polymerase (RdRp) activity, induction of lethal mutagenesis, or inhibition of the viral NS6 protease to prevent polyprotein cleavage.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Murine norovirus replication machinery.